Reply to: Utilizing foundation models for developing clinical tools

This reply addresses Chan et al.'s comments on our previous study, clarifying the use of foundation models (e.g., RETFound), commercial data sources/anonymity, and DeLong test results. We highlight that the SDEDS-fine-tuned RETFound outperforms commercial models and acknowledge the need for further testing, while referencing an early benchmark value.